United Imaging Intelligence Showcases Advanced AI Solutions at ECR 2026
At the European Congress of Radiology (ECR) 2026, held under the theme 'Rays of Knowledge', United Imaging Intelligence (UII) presented a comprehensive suite of pioneering artificial intelligence (AI) solutions geared towards revolutionizing the field of radiology. This unveiling aimed to demonstrate the tangible value that clinical validation, technological scalability, and day-to-day application of AI can bring to modern healthcare.
One of the highlights of UII's presentation was the introduction of over 30 CE-certified AI medical applications, establishing one of the most extensive AI-driven product portfolios in the European market. The organization showcased these advanced solutions through its unified Clinical Portal (uAI) which integrates more than 60 AI applications spanning diverse imaging modalities and core areas of diseases including neuroradiology, cardiovascular health, oncology, and more. Experts from Europe, Asia, North America, and South America praised the portfolio for its extensive coverage, describing it as 'truly comprehensive'. They noted its distinctiveness as an all-inclusive AI solution that significantly supports clinical professionals in their daily practices.
This robust regulatory foundation, coupled with proven clinical applicability, underscores UII's dedication to delivering scalable, intelligent healthcare solutions that comply with international regulations. Expanding upon validated radiological knowledge, UII introduced the uAI NEXUS suite of medical foundation models, which encompasses images, language, speech, and video. Essentially, the large-scale medical imaging model is trained on tens of millions of datasets and refined through real-world implementation, transforming domain knowledge into scalable AI capabilities. These multimodal foundational models enhance UII's AI medical agents by incorporating advanced reasoning capabilities directly into clinical workflows.
The debut of the uAI Insight Image-to-Report AI agent in Europe marks a significant leap in diagnostics, demonstrating the ability to detect up to 73 thoracic findings and 47 neurological findings from a single examination while generating structured preliminary reports automatically to streamline interpretation.
Moreover, the uAI Ultrasound agent, which integrates multimodal foundational models and digital twin technology, exhibited consistent high-quality scanning and real-time AI-based reporting. Live demonstrations highlighted the capability of embedded AI to operate directly at the point of care. In addition to these flagship innovations, UII showcased a broader ecosystem of AI agents encompassing imaging diagnosis, surgical planning, hospital operations, and clinical research. Collectively, these solutions represent a shift from single-task algorithms to collaborative intelligence oriented towards enhancing workflow across the healthcare system.
The true value of clinically validated AI is realized only when it leads to better patient care. UII's AI solutions are already empowering healthcare professionals across Europe, including Poland, the UK, Italy, Romania, and Bosnia and Herzegovina. Ongoing collaborations in additional countries further aim to expand access to AI-based diagnostics for a wide patient population throughout the region. For instance, UII's CE-certified FFR-CT AI solution enables rapid, non-invasive assessment of coronary blood flow, facilitating therapeutic decision-making for Dr. Armando Fusco. This not only shortens hospital stays for emergency patients but also helps avoid unnecessary invasive procedures in complex cases, especially in those with moderate stenosis.
At STERMED, UII's CE-marked AI applications for MRI imaging of the prostate and liver serve as trusted clinical assistants for Dr. Marcin Sternicki, improving diagnostic reliability by providing precise quantitative measurements that are otherwise difficult and time-consuming to obtain manually. Furthermore, the AI for prostate MRI can automatically generate a structured PI-RADS sector map, offering clear visual documentation to support clinical decision-making.
During ECR 2026, UII reiterated its foundational principles for AI development, which emphasize clinical validation, regulatory rigor, and measurable outcomes. This approach transforms radiological knowledge into a dynamic data cycle, continually evolving to elevate clinical standards and promote intelligent healthcare throughout Europe and beyond. (Note that referenced products and features may not be available in all countries, and future availability cannot be guaranteed. Not all AI applications presented are CE-marked or FDA-approved.)
One of the highlights of UII's presentation was the introduction of over 30 CE-certified AI medical applications, establishing one of the most extensive AI-driven product portfolios in the European market. The organization showcased these advanced solutions through its unified Clinical Portal (uAI) which integrates more than 60 AI applications spanning diverse imaging modalities and core areas of diseases including neuroradiology, cardiovascular health, oncology, and more. Experts from Europe, Asia, North America, and South America praised the portfolio for its extensive coverage, describing it as 'truly comprehensive'. They noted its distinctiveness as an all-inclusive AI solution that significantly supports clinical professionals in their daily practices.
This robust regulatory foundation, coupled with proven clinical applicability, underscores UII's dedication to delivering scalable, intelligent healthcare solutions that comply with international regulations. Expanding upon validated radiological knowledge, UII introduced the uAI NEXUS suite of medical foundation models, which encompasses images, language, speech, and video. Essentially, the large-scale medical imaging model is trained on tens of millions of datasets and refined through real-world implementation, transforming domain knowledge into scalable AI capabilities. These multimodal foundational models enhance UII's AI medical agents by incorporating advanced reasoning capabilities directly into clinical workflows.
The debut of the uAI Insight Image-to-Report AI agent in Europe marks a significant leap in diagnostics, demonstrating the ability to detect up to 73 thoracic findings and 47 neurological findings from a single examination while generating structured preliminary reports automatically to streamline interpretation.
Moreover, the uAI Ultrasound agent, which integrates multimodal foundational models and digital twin technology, exhibited consistent high-quality scanning and real-time AI-based reporting. Live demonstrations highlighted the capability of embedded AI to operate directly at the point of care. In addition to these flagship innovations, UII showcased a broader ecosystem of AI agents encompassing imaging diagnosis, surgical planning, hospital operations, and clinical research. Collectively, these solutions represent a shift from single-task algorithms to collaborative intelligence oriented towards enhancing workflow across the healthcare system.
The true value of clinically validated AI is realized only when it leads to better patient care. UII's AI solutions are already empowering healthcare professionals across Europe, including Poland, the UK, Italy, Romania, and Bosnia and Herzegovina. Ongoing collaborations in additional countries further aim to expand access to AI-based diagnostics for a wide patient population throughout the region. For instance, UII's CE-certified FFR-CT AI solution enables rapid, non-invasive assessment of coronary blood flow, facilitating therapeutic decision-making for Dr. Armando Fusco. This not only shortens hospital stays for emergency patients but also helps avoid unnecessary invasive procedures in complex cases, especially in those with moderate stenosis.
At STERMED, UII's CE-marked AI applications for MRI imaging of the prostate and liver serve as trusted clinical assistants for Dr. Marcin Sternicki, improving diagnostic reliability by providing precise quantitative measurements that are otherwise difficult and time-consuming to obtain manually. Furthermore, the AI for prostate MRI can automatically generate a structured PI-RADS sector map, offering clear visual documentation to support clinical decision-making.
During ECR 2026, UII reiterated its foundational principles for AI development, which emphasize clinical validation, regulatory rigor, and measurable outcomes. This approach transforms radiological knowledge into a dynamic data cycle, continually evolving to elevate clinical standards and promote intelligent healthcare throughout Europe and beyond. (Note that referenced products and features may not be available in all countries, and future availability cannot be guaranteed. Not all AI applications presented are CE-marked or FDA-approved.)
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.